n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid has been researched along with Carcinoma, Lewis Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borgman, MP; Coleman, T; Geyser-Stoops, S; Ghandehari, H; Kolhatkar, RB; Line, BR | 1 |
1 other study(ies) available for n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid and Carcinoma, Lewis Lung
Article | Year |
---|---|
Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A''-DTPA) conjugates show increased kidney accumulation.
Topics: Acrylamides; Animals; Binding, Competitive; Carcinoma, Lewis Lung; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Endothelial Cells; Female; Humans; Indium Radioisotopes; Injections, Intravenous; Integrin alphaVbeta3; Isothiocyanates; Kidney; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Molecular Weight; Neoplasm Transplantation; Pentetic Acid; Peptides, Cyclic; Radionuclide Imaging; Tissue Distribution | 2008 |